{"id":"W4402565842","doi":"10.1016/j.annonc.2024.08.2269","title":"LBA30 ATHENA-COMBO, a phase III, randomized trial comparing rucaparib (RUCA) + nivolumab (NIVO) combination therapy vs RUCA monotherapy as maintenance treatment in patients (pts) with newly diagnosed ovarian cancer (OC)","year":2024,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Nivolumab; Internal medicine; Oncology; Ovarian cancer; Maintenance therapy; Cancer; Chemotherapy; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009333698,0.001373891,0.002324851,0.0003599622,0.0003497937,0.001154498,0.0008205262,0.001237092,0.007105947],"category_scores_gemma":[0.001184584,0.0005750087,0.001779332,0.0003835831,0.0007243379,0.0007883853,0.0003631569,0.003579438,0.001325499],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007040567,"about_ca_system_score_gemma":0.001060011,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001544637,"about_ca_topic_score_gemma":0.005620839,"domain_scores_codex":[0.9997143,0.0001342031,0.00001512827,0.00006217355,0.00001974134,0.00005437135],"domain_scores_gemma":[0.9994972,0.0001157306,0.0001003974,0.00003784585,0.00003045141,0.0002182292],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9447267,0.005541841,0.001423238,0.001166081,0.001983178,0.00006054645,0.000057032,0.0006297185,0.004793537,0.0002623054,0.003567546,0.03578826],"study_design_scores_gemma":[0.9557441,0.03861547,0.002245172,0.00004857102,0.0008139313,0.00006351442,0.00002489899,0.0005065499,0.0002893849,0.0002046889,0.001427997,0.00001567914],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9676032,0.01365705,0.0009223674,0.001887144,0.001129438,0.003529523,0.004153816,0.0004152316,0.006702106],"genre_scores_gemma":[0.9739465,0.005449162,0.00213024,0.002555625,0.0005392952,0.003220488,0.004295356,0.00005867173,0.007804644],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007105947,"threshold_uncertainty_score":0.02377176,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06469292880486023,"score_gpt":0.4006312534292779,"score_spread":0.3359383246244176,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}